Back to search

Article

Notoginsenoside R1 targets PPAR-γ to inhibit Hepatic Stellate Cell activation and ameliorates liver fibrosis

2023-06-27

Abstract excerpt

<h4>Background: </h4> Hepatic fibrosis, a common pathological process that occurs in end-stage liver diseases, is a serious public health problem and lacks effective therapy. Notoginsenoside R1 (NR1) is a small molecule derived from the traditional Chinese medicine Sanqi, exhibiting great potential in treating diverse metabolie disorders. Here we aimed to enquired the role of NR1 in liver fibrosis and its underlyi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e4687c9c-cf73-5bd5-aa13-0b50f858c19f
DOI
10.22541/au.168785471.11911916/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Notoginsenoside R1 targets PPAR-γ to inhibit Hepatic Stellate Cell activation and ameliorates liver fibrosisDOI 10.22541/au.168785471.11911916/v1
Integrating Network Pharmacology and Experimental Validation to Elucidate Huaier in Attenuating Liver Fibrosis via the AKT Signaling PathwaySemantic proximity
Identify Key Active Ingredients and Molecular Mechanisms of Jiangzhi Decoction on Non-alcoholic Fatty Liver Disease by Network Pharmacology AnalysisSemantic proximity
Mechanisms of Cynarine for treatment of Non-alcoholic Fatty Liver Disease Based on the Integration of Network Pharmacology, Molecular Docking and Cell ExperimentSemantic proximity
Ranscriptome Analysis Reveals the Molecular Mechanism of Yiqi Rougan Decoction in Reducing CCl4-induced Liver Fibrosis in RatsSemantic proximity
Exploring the Mechanism of Dendrobine in Treating Non-Alcoholic Fatty Liver Disease Based on Network Pharmacology and Experimental ValidationSemantic proximity
Exploring anti-nonalcoholic fatty liver disease mechanism of Gardeniae Fructus by combining an animal model with network pharmacology and molecular dockingSemantic proximity
Huanglian-Hongqu herb pair improves nonalcoholic fatty liver disease via NF-κB/NLRP3 pathway in mice: network pharmacology, molecular docking and experimental validationSemantic proximity
Exploration of potential targets and mechanisms of naringenin in the treatment of nonalcoholic fatty liver disease through network pharmacologySemantic proximity
SUMOylation inhibitors synergize with FXR agonists in combating liver fibrosisSemantic proximity
Jiangzhi Granule attenuates non-alcoholic steatohepatitis by suppressing TNF/NFκB signaling pathway-a study based on network pharmacology.Semantic proximity
Investigation of the potential mechanism of the Shugan Xiaozhi decoction for the treatment of nonalcoholic fatty liver disease based on network pharmacology and molecular dockingSemantic proximity
Advanced Strategies in Enhancing the Hepatoprotective Efficacy of Natural Products: Integrating Nanotechnology, Genomics, and Mechanistic InsightsSemantic proximity
Select a neighboring publication to make it the new centre.